NeuroPace(NPCE)
MOUNTAIN VIEW, CAMedical Devices
Focus: NeuroPace is a public medical device company specializing in implantable neurological treatments, particularly responsive neurostimulation (RNS) systems for epilepsy management. The company generated $80M in revenue in FY 2025 with a focused pipeline in neuromodulation.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
7
Should You Work at NeuroPace?
AI assessmentViable for specialists seeking deep neurotech expertise in a stabilizing commercial business, but cash burn and size constraints limit upside mobility and stability.
Why Work Here
- Implantable neurotech is a high-barrier, capital-intensive space with limited competition, offering job security in a specialized market
- Commercial expansion is active (5 open roles) with revenue growing 23% YoY ($65M to $80M), signaling confidence in market adoption
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$80M
Key Products
RNS® System
Growing
Growth
Flagship implantable system in Phase 3-4 development with multiple trial tracks, driving commercial expansion and revenue growth.
Pipeline & Clinical Trials
Help build intelligence for NeuroPace
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.